Suboxone 12/3
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Suboxone 12/3." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109920/all/Suboxone_12_3.
Vallerand AHA, Sanoski CAC, . Suboxone 12/3. Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109920/all/Suboxone_12_3. Accessed January 21, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Suboxone 12/3. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109920/all/Suboxone_12_3
Vallerand AHA, Sanoski CAC, . Suboxone 12/3 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 January 21]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109920/all/Suboxone_12_3.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Suboxone 12/3
ID - 109920
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109920/all/Suboxone_12_3
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -